BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2015

Position Statistics

Total Positions 92
New Positions 9
Increased Positions 25
Decreased Positions 30
Positions with Activity 55
Sold Out Positions 11
Total Mkt Value (in $ millions) 1,058

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.47%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 74.77%
Services
Technology
Transportation
Utilities

9 New Positions as of 12/31/2015

Company Class ▲ Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held
AMAG PHARMACEUTICALS INC COM 7,956 7,956 New 300,000
DEPOMED INC COM 12,611 12,611 New 725,600
ENDOLOGIX INC COM 11,210 11,210 New 1,000,000
PROTALIX BIOTHERAPEUTICS INC COM 2,754 2,754 New 3,338,570
ST JUDE MED INC COM 15,240 15,240 New 200,000
VALEANT PHARMACEUTICALS INTL I COM 30,024 30,024 New 900,000
TITAN PHARMACEUTICALS INC DEL COM NEW 4,529 4,529 New 761,201
NEXVET BIOPHARMA PUB LTD CO ORD SHS 2,158 2,158 New 721,595
STRONGBRIDGE BIOPHARMA PLC SHS USD 8,615 8,615 New 1,656,705


Create your free portfolio